Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Incorvaia

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Mycopathologia|October 6, 2005
Endogenous Aspergillus versicolor endophthalmitis in an immuno-competent HIV-positive patientPaolo Perri, Claudio Campa, Carlo Incorvaia, et al.
Ophthalmology|January 2, 2010
Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopiaFrancesco Parmeggiani, Donato Gemmati, Ciro Costagliola, et al.
British Journal of Clinical Pharmacology|September 20, 2006
Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timololCiro Costagliola, Claudio Campa, Francesco Parmeggiani, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 16, 2007
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucomaCiro Costagliola, Francesco Parmeggiani, Gianni Virgili, et al.
American Journal of Ophthalmology|September 15, 2004
Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhageFrancesco Parmeggiani, Ciro Costagliola, Carlo Incorvaia, et al.
Mediators of Inflammation|September 28, 2010
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implicationsClaudio Campa, Ciro Costagliola, Carlo Incorvaia, et al.
American Journal of Ophthalmology|September 5, 2002
Mesectodermal leiomyoma exclusively involving the posterior choroidPaolo Perri, Beatrice Paduano, Carlo Incorvaia, et al.
Investigative Ophthalmology & Visual Science|April 2, 2008
Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degenerationFrancesco Parmeggiani, Ciro Costagliola, Donato Gemmati, et al.
Pharmacogenetics and Genomics|November 16, 2007
Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degenerationFrancesco Parmeggiani, Ciro Costagliola, Donato Gemmati, et al.
Retina (Philadelphia, Pa.)|February 28, 2008
12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degenerationCarlo Incorvaia, Claudio Campa, Francesco Parmeggiani, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Mycopathologia|October 6, 2005
Endogenous Aspergillus versicolor endophthalmitis in an immuno-competent HIV-positive patientPaolo Perri, Claudio Campa, Carlo Incorvaia, et al.
Ophthalmology|January 2, 2010
Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopiaFrancesco Parmeggiani, Donato Gemmati, Ciro Costagliola, et al.
British Journal of Clinical Pharmacology|September 20, 2006
Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timololCiro Costagliola, Claudio Campa, Francesco Parmeggiani, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 16, 2007
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucomaCiro Costagliola, Francesco Parmeggiani, Gianni Virgili, et al.
American Journal of Ophthalmology|September 15, 2004
Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhageFrancesco Parmeggiani, Ciro Costagliola, Carlo Incorvaia, et al.
Mediators of Inflammation|September 28, 2010
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implicationsClaudio Campa, Ciro Costagliola, Carlo Incorvaia, et al.
American Journal of Ophthalmology|September 5, 2002
Mesectodermal leiomyoma exclusively involving the posterior choroidPaolo Perri, Beatrice Paduano, Carlo Incorvaia, et al.
Investigative Ophthalmology & Visual Science|April 2, 2008
Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degenerationFrancesco Parmeggiani, Ciro Costagliola, Donato Gemmati, et al.
Pharmacogenetics and Genomics|November 16, 2007
Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degenerationFrancesco Parmeggiani, Ciro Costagliola, Donato Gemmati, et al.
Retina (Philadelphia, Pa.)|February 28, 2008
12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degenerationCarlo Incorvaia, Claudio Campa, Francesco Parmeggiani, et al.
Pageof 3